These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38604924)

  • 1. Retraction notice to "Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities" [Bioorg. Med. Chem. Lett. 22(9) (2012) 3067-3071].
    Chang M; Lee SH; Kim HJ; Koh JS; Kim A
    Bioorg Med Chem Lett; 2024 May; 104():129734. PubMed ID: 38604924
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities.
    Kim HJ; Lee SH; Koh JS; Lee SH
    Bioorg Med Chem Lett; 2012 May; 22(9):3067-71. PubMed ID: 22497764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction notice to "Sannastatin, a novel toxic macrolactam polyketide glycoside produced by actinomycete Streptomyces sannanensis" [Bioorg. Med. Chem. Lett. 21 (2011) 3905-3908].
    Yang SX; Gao JM; Zhang AL; Laatsch H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4219. PubMed ID: 28826506
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Two novel bioactive glucosinolates from broccoli (Brassica oleracea L. var. italica) florets" [Bioorg. Med. Chem. Lett. 22 (2012) 5555-5558].
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6201. PubMed ID: 24288810
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Synthesis and bioevaluation of aryl-guanidino polyamine conjugates targeting the polyamine transporter" [Bioorg. Med. Chem. Lett. 20 (2010) 6421-6425].
    Wang J; Chen Z; Xie S; Zhao J; Wang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128251. PubMed ID: 34256984
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I" [Bioorg. Med. Chem. Lett. 17 (2007) 4604-4612].
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5281. PubMed ID: 17987674
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
    Lamie PF
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease" [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902].
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1035. PubMed ID: 19434916
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research" [Bioorg. Med. Chem. Lett. 29 (2019) 2016-2024].
    Zhao L; Sun N; Tian L; Zhao S; Sun B; Sun Y; Zhao D
    Bioorg Med Chem Lett; 2021 Aug; 45():128140. PubMed ID: 34052643
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Solid-phase synthesis of Biotin-S-Farnesyl-l-Cysteine, a surrogate substrate for isoprenylcysteine Carboxylmethyltransferase (ICMT)" [Bioorg. Med. Chem. Lett. 23 (2013) [5671-5673].
    Stevenson GI; Yong S; Fechner GA; Neve J; Lock A; Avery VM
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2575. PubMed ID: 30007572
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis" [Bioorg. Med. Chem. 19 (2011) 5175-82].
    Bioorg Med Chem; 2015 Jan; 23(1):272. PubMed ID: 25671237
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].
    Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].
    Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands" [Bioorg. Med. Chem. 18 (4) (2010) 1434–1440].
    Bioorg Med Chem; 2014 Jun; 22(12):3227. PubMed ID: 24955474
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2009 Jan; 17(2):930. PubMed ID: 19177601
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core" [Bioorg. Med. Chem. Lett. 26 (2016) 5399-5402].
    Han M; Wang C; Ji Y; Song Z; Xing L; Su Y; Wang X; Zhang A; Ai J; Geng M
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126931. PubMed ID: 31902709
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Challenges in the development of an M
    Tarr JC; Wood MR; Noetzel MJ; Melancon BJ; Lamsal A; Luscombe VB; Rodriguez AL; Byers FW; Chang S; Cho HP; Engers DW; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Jeffrey Conn P; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2018 Sep; 28(17):3014. PubMed ID: 30076050
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].
    Sheffler DJ; Nedelcovych MT; Williams R; Turner SC; Duerk BB; Robbins MR; Jadhav SB; Niswender CM; Jones CK; Conn PJ; Nathan Daniels R; Lindsley CW
    Bioorg Med Chem Lett; 2017 May; 27(9):2079. PubMed ID: 28347668
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Syntheses and antimicrobial activities of ogipeptin derivatives" [Bioorg. Med. Chem. Lett. 42 (2021) 128093].
    Takiguchi S; Homma H; Fujisawa T; Hirota-Takahata Y; Ono Y; Kizuka M; Ishii Y; Yoshimura S; Nishi T
    Bioorg Med Chem Lett; 2021 Sep; 47():128228. PubMed ID: 34192636
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Oleanane-type triterpenoids from Panax stipuleanatus and their anticancer activities" [Bioorg. Med. Chem. Lett. 20(23) (2010) 7110-7115].
    Liang C; Ding Y; Nguyen HT; Kim JA; Boo HJ; Kang HK; Nguyen MC; Kim YH
    Bioorg Med Chem Lett; 2021 Jun; 41():128014. PubMed ID: 33867227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.